| 영문 | malignant melanoma | 한글 | 악성흑색종 |
|---|---|---|---|
| 설명 | 피부에서 생기는 암의 일종. 주로 백인에게 호발하며, 50대~70대에 많이 발생하고, 젊은 여성에게 증가하는 경향이 있으며, 피부암중 1~3%를 차지하는 드문 병으로 피부와 기타 기관의 멜라닌 세포계에서 유래하는 악성종양이다. 원인으로 일광노출과 직접적인 관계가 있으며 가족적 발생도 볼 수 있다. |
||
| 영문 | iris | 한글 | 홍채 |
|---|---|---|---|
| 설명 | 안구의 각막과 수정체 사이에 있는 둥근 모양의 얇은 막. 막의 중앙에 동공이 있으며, 홍채의 신축으로 동공이 축소되거나 확대되어 안구에 들어오는 빛의 양을 조절한다. 인종에 따라 색소가 다른다. 눈동자의 주위에 있는 고리 모양의 막, 검은 눈동자의 본체는 각막을 통해 흑색으로 보이는 홍채이다. 중앙에 원형의 동공이 있고, 이 곳을 통하여 전안방과 후안방이 이어진다. 홍채가 이완하거나 수축함에 따라 동공의 크기가 변하고 따라서 망막에 달하는 광선의 양이 조절된다. 즉, 홍채는 카메라의 조리개에 해당한다. 홍채의 이완과 수축은 그 속에 있는 동공산대근 및 동공조임근에 의하여 이루어진다. 홍채의 외주연은 섬모체연이라고 하며, 모양체에 연결되어 있다. 또 내측연, 즉 동공의 외주연은 동공연이라고 한다. 홍채의 조직은 색소세포가 풍부한 층으로 되어 있는데, 그 색소의 빛깔이나 혈관의 다소에 의하여 홍채의 빛깔이 달라 보인다.  |
||
| MM | macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle... |
|---|---|
| ICL | idiopathic CD4 T-cell lymphocytopenia; iris-clip lens; isocitrate lyase |
| IRIS | integrated risk information system; interleukin regulation of immune system; International Research ... |
| VID | visible iris diameter |
| ABCD | airway, breathing, circulation, differential diagnosis (or defibrillate) [in cardiopulmonary resusci... |
| IPE | Iris pigment epithelium |
|---|---|
| ICB | iris ciliary body |
| IPE | iris pigment epithelial |
| ALM | Acral lentiginous melanoma |
| A-Mel-3 | Amelanotic melanoma |
| acral lentiginous melanoma | <tumour> A form of malignant lentigo melanoma that occurs in acral areas not excessively exposed to sunlight and where hair follicles are absent. (05 Mar 2000) |
|---|---|
| amelanotic melanoma | <tumour> An anaplastic melanoma consisting of cells derived from melanocytes but not forming melanin. (05 Mar 2000) |
| benign juvenile melanoma | A benign, slightly pigmented or red superficial small skin tumour composed of spindle-shaped, epithelioid, and multinucleated cells that may appear atypical; most common in children, but also appearing in adults. Synonym: benign juvenile melanoma, epithelioid cell nevus, spindle cell nevus. (05 Mar 2000) |
| cancer, malignant melanoma | A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. Melanoma can be cured if detected early, before spread (metastasis) to other areas of the body. Diagnosis is confirmed with a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma. (12 Dec 1998) |
| cancer, melanoma | A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. It can be cured if detected early, before spread (metastasis) to other areas. Diagnosis is confirmed by a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma. (12 Dec 1998) |
| malignant lentigo melanoma | <tumour> A melanoma arising from a malignant lentigo. (05 Mar 2000) |
| malignant melanoma | <oncology, tumour> A malignant tumour which arises from the pigment producing cells (melanosomes) of the deeper layers of the skin (or the eye). Melanoma is the leading cause of death attributable to skin lesions. Described as an irregular dark skin lesion that may have areas of varying colour. Often greater than 6 mm in diameter. (27 Sep 1997) |
| malignant melanoma: gallium imaging | <radiology> Greater than50% sensitivity for primary and metastatic sites: 73% sensitivity if lesion is greater than 2 cm, 17% sensitivity if less than 2 cm, see: gallium: indications malignant melanoma (12 Dec 1998) |
| malignant melanoma in situ | A melanoma limited to the epidermis and composed of nests of atypical melanocytes and scattered single cells extending into the upper epidermis; local excision is curative although the lesion, if untreated, may soon invade the dermis. Malignant lentigo may be considered a slowly progressive type of malignant melanoma in situ. (05 Mar 2000) |
| malignant melanoma: staging | <radiology> Clark staging: level I: all tumour cells above basement membrane (in situ), level II: tumour extends to papillary dermis, level III: tumour extends to interface between papillary and reticular dermis, level IV: tumour extends between bundles of collagen of reticular dermis, level V: tumour invasion of sucutaneous tissue (87% metastases) Breslow staging: thin: less than 0.75 mm depth of invasion, intermediate: 0.76 - 3.99 mm depth of invasion, thick: greater than 4 mm depth of invasion see: malignant melanoma (12 Dec 1998) |
| melanoma | <oncology, tumour> A tumour arising from the melanocytic system of the skin and other organs. When used alone the term refers to malignant melanoma. (18 Nov 1997) |
| melanoma, amelanotic | An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. (12 Dec 1998) |
| melanoma growth stimulatory activity | Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils. (18 Nov 1997) |
| minimal deviation melanoma | <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis. (05 Mar 2000) |
| Cloudman melanoma | <tumour> A transplantable melanoma that arose spontaneously in a mouse of DBA strain, and which grows and metastasizes in mice of related strains. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|